Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
603811 CG​

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Class A(603811 CG)

$6.63+0.071.07%(Market Closed · 07:00:02 UTC · (15 min delay))

Overview

Profile

Financials & Metrics

FinancialsChartingEmployees

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Class A — Company Profile

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, food, capsules, tablets, traditional Chinese medicines, preparations, pharmaceutical intermediates in China and internationally. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is based in Shanghai, China.

Sector
Health Care
Industry
Pharmaceuticals
Exchange
CG
CEO
Chun Jian Zhao
Headquarters
Shanghai, SH, CN
IPO Date
Mar 15, 2017
Employees
604
Website
www.chengyipharma.com

Key Metrics

Price
$6.99
Market Cap
$3.20B
Revenue (TTM)
$201.00M
Net Income (TTM)
$44.29M
EPS (TTM)
0.14
P/E (TTM)
18.04
P/B (TTM)
2.26
Dividend Yield
2.78%
ROE (TTM)
3.05%
ROA (TTM)
2.49%
Operating Margin
25.03%
Beta
0.24

Dividends

Last Dividend
$0.25
Last Yield
0.03%

Summary

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, food, capsules, tablets, traditional Chinese medicines, preparations, pharmaceutical intermediates in China and internationally. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is based in Shanghai, China.

Website
www.chengyipharma.com
Location
Shanghai, SH, CN
Phone86 577 6348 9509
Employees604
CEOChun Jian Zhao
Sector
Health Care
Industry
Pharmaceuticals
IPO DateMar 15, 2017

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Key Stats

Trading

Px/Chg 1D$6.99 / +0.58%
Avg Volume5.95M
Beta0.24
Mkt Cap3.20B
FD Mkt Cap3.29B

Float

Shrs Out/Float458.23M / 396.06M
Short Float0.00%
Days to Cover0.00
Stock Repurchased$0.00

Current Valuation

EV3.17B
EV/EBITDA11.74
EV/Sales3.83
P/B2.26
P/S3.87
FCF Yield2.32%
ROE3.05%
ROA2.49%
Current Ratio1.74

Dividend

Cash$0.25
Yield2.78%
Yield (TTM)2.78%

Estimates

P/E18.04
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgMar '23Mar '24Mar '25Mar '26Sep '26
PRICE-BASED RATIOS
Price / Earnings38.4025.5315.8614.5272.7463.33
Price / Sales9.166.303.854.0817.7013.88
Price / Book Value2.653.792.172.312.742.26
Price / Free Cash Flow20.86-47.4620.8519.9967.7843.13
ENTERPRISE VALUE METRICS
Enterprise Value3,361.24,341.72,737.52,937.43,618.33,171.2
Enterprise Value / Sales9.076.634.084.1116.8013.74
Enterprise Value / EBITDA24.4518.5010.269.0743.0241.39
Enterprise Value / EBIT34.3725.0814.4512.8160.0059.51

Financials

Full Financials
Millions CNY5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue4%694.0655.0671.6714.4812.3
Gross Income4%485.0437.2423.2489.2567.0
EBITDA5.8%257.6234.6266.7323.9322.4
EBIT2.9%202.9173.1189.4229.3227.7
Net Income3.4%170.8161.6162.9200.7195.1
EPS (Diluted)4.1%0.520.490.500.610.61
BALANCE SHEET
Cash & ST Inv27.6%83.3213.5294.1173.0220.7
Total Assets6.5%1,322.51,719.11,892.81,728.41,702.3
Total Liabilities-1.5%323.6628.2696.2463.3304.6
Total Shareholder Equity9%986.31,087.91,192.31,260.11,390.5
CASH FLOW
Net Operating Cash Flow18.2%143.5165.9194.8205.7280.4
Cap Ex-23.7%-134.1-252.9-70.9-59.9-45.4
Free Cash Flow123.7%9.4-86.9123.9145.8235.0

Enterprise Value Bridge

Millions CNY23 Oct '26
Price (As of 23 Oct '26)6.47
Basic Shares458.23
Market Cap2,964.7
Diluted Shares444.76
Fully Diluted Shares Outstanding444.76
Fully Diluted Market Cap2,877.6
+Consolidated Debt126.4
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-166.4
−Short-term Investments-90.1
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest8.2
+Pension Liabilities—
Enterprise Value2,932.9

Related companies

Eli Lilly and Company

LLY US

Johnson & Johnson

JNJ US

AbbVie Inc.

ABBV US

Merck & Co., Inc.

MRK US

Novartis Ag

NVS US

Astrazeneca Plc

AZN US

Abbott Laboratories

ABT US

Novo Nordisk A/S

NVO US

Pfizer Inc

PFE US

Vertex Pharmaceuticals Inc / Ma

VRTX US

Bristol Myers Squibb Company

BMY US

Csl Ltd

CSLLY US